State Street Corp Astrazeneca PLC Transaction History

State Street Corp

$2.8 Trillion
Q3 2025

A detailed history of State Street Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, State Street Corp holds 967,149 shares of AZN stock, worth $86.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

967,149

Previous 938,997 3.0%

Holding current value

$86.5 Million

Previous $65.6 Million 13.08%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$68.72 - $82.11 $1.93 Million - $2.31 Million	28,152 Added 3.0%	967,149 $74.2 Million
Q2 2025 Aug 14, 2025	SELL	$64.87 - $75.0 $3.86 Million - $4.47 Million	-59,558 Reduced 5.96%	938,997 $65.6 Million
Q1 2025 May 15, 2025	SELL	$65.37 - $77.96 $13.2 Million - $15.7 Million	-201,227 Reduced 16.77%	998,555 $73.4 Million
Q4 2024 Feb 14, 2025	SELL	$63.2 - $79.58 $39 Million - $49.2 Million	-617,842 Reduced 33.99%	1,199,782 $78.6 Million
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $39.2 Million - $44.9 Million	-511,916 Reduced 21.97%	1,817,624 $142 Million

Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $25.8 Million - $31.2 Million	-385,961 Reduced 14.21%	2,329,540 $182 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $71.3 Million - $81.2 Million	1,167,688 Added 75.44%	2,715,501 $184 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $9.66 Million - $10.8 Million	156,018 Added 11.21%	1,547,813 $104 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $9.38 Million - $10.4 Million	144,582 Added 11.59%	1,391,795 $94.3 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $58.1 Million - $63 Million	-830,845 Reduced 39.98%	1,247,213 $89.3 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $33.1 Million - $37.5 Million	523,358 Added 33.66%	2,078,058 $144 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $9.93 Million - $12.9 Million	-183,130 Reduced 10.54%	1,554,700 $105 Million
Q3 2022 Nov 15, 2022	BUY	$53.02 - $135.75 $16.3 Million - $41.7 Million	307,478 Added 21.5%	1,737,830 $95.3 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $12.5 Million - $15 Million	-210,348 Reduced 12.82%	1,430,352 $94.5 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $2.61 Million - $3.15 Million	-46,860 Reduced 2.78%	1,640,700 $109 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $7.18 Million - $8.48 Million	132,879 Added 8.55%	1,687,560 $98.3 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $73.1 Million - $79.9 Million	1,314,811 Added 548.13%	1,554,681 $93.4 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $2.45 Million - $3.05 Million	-50,696 Reduced 17.45%	239,870 $14.4 Million
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $7.75 Million - $8.95 Million	-164,369 Reduced 36.13%	290,566 $14.4 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $18.6 Million - $22.2 Million	382,830 Added 530.93%	454,935 $22.8 Million
Q3 2020 Nov 10, 2020	SELL	$53.07 - $61.1 $1.02 Million - $1.18 Million	-19,290 Reduced 21.11%	72,105 $3.95 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $233,041 - $299,061	5,407 Added 6.29%	91,395 $4.83 Million
Q1 2020 May 11, 2020	BUY	$37.79 - $51.33 $3.25 Million - $4.41 Million	85,988 New	85,988 $3.84 Million

Others Institutions Holding AZN

# of Institutions

1,501

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Astrazeneca PLC Transaction History